| 000 | 01693 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250515100528.0 | ||
| 264 | 0 | _c20080826 | |
| 008 | 200808s 0 0 eng d | ||
| 022 | _a1619-7070 | ||
| 024 | 7 |
_a10.1007/s00259-007-0650-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOhira, Hiroshi | |
| 245 | 0 | 0 |
_aMyocardial imaging with 18F-fluoro-2-deoxyglucose positron emission tomography and magnetic resonance imaging in sarcoidosis. _h[electronic resource] |
| 260 |
_bEuropean journal of nuclear medicine and molecular imaging _cMay 2008 |
||
| 300 |
_a933-41 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCardiomyopathies _xdiagnosis |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFluorodeoxyglucose F18 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImage Enhancement _xmethods |
| 650 | 0 | 4 |
_aMagnetic Resonance Imaging _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPositron-Emission Tomography _xmethods |
| 650 | 0 | 4 | _aRadiopharmaceuticals |
| 650 | 0 | 4 | _aReproducibility of Results |
| 650 | 0 | 4 |
_aSarcoidosis _xdiagnosis |
| 650 | 0 | 4 | _aSensitivity and Specificity |
| 650 | 0 | 4 | _aSubtraction Technique |
| 700 | 1 | _aTsujino, Ichizo | |
| 700 | 1 | _aIshimaru, Shinji | |
| 700 | 1 | _aOyama, Noriko | |
| 700 | 1 | _aTakei, Toshiki | |
| 700 | 1 | _aTsukamoto, Eriko | |
| 700 | 1 | _aMiura, Masatake | |
| 700 | 1 | _aSakaue, Shinji | |
| 700 | 1 | _aTamaki, Nagara | |
| 700 | 1 | _aNishimura, Masaharu | |
| 773 | 0 |
_tEuropean journal of nuclear medicine and molecular imaging _gvol. 35 _gno. 5 _gp. 933-41 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00259-007-0650-8 _zAvailable from publisher's website |
| 999 |
_c17597693 _d17597693 |
||